SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-20-271093
Filing Date
2020-10-16
Accepted
2020-10-16 16:09:52
Documents
2
Group Members
ALAIN COHENCOBRO OPPORTUNITY FUND GP, LLCMARC COHENTODD KALOUDIS

Document Format Files

Seq Description Document Type Size
1 SC 13D d91837dsc13d.htm SC 13D 108846
2 EX-99.1 d91837dex991.htm EX-99.1 5145
  Complete submission text file 0001193125-20-271093.txt   115627
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Subject) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91763 | Film No.: 201244079
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1000 WILSON BLVD. #1800 ARLINGTON VA 22209
Business Address 1000 WILSON BLVD. #1800 ARLINGTON VA 22209 703-879-6522
COBRO VENTURES OPPORTUNITY FUND, L.P. (Filed by) CIK: 0001795025 (see all company filings)

IRS No.: 843744460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D